The Migraine–Stroke Connection

키워드

참고문헌 (135)

1. "The International Classification of Headache Disorders, 3rd edition (beta version)", Cephalalgia, 33, pp.629~808 (2013)
2. Milhaud D, "Ischemic stroke and active migraine", Neurology, 57, pp.1805~1811 (2001)
3. Sochurkova D, "Migraine history and migraine-induced stroke in the Dijon stroke registry", Neuroepidemiology, 18, pp.85~91 (1999)
4. Arboix A, "Migrainous cerebral infarction in the Sagrat Cor Hospital of Barcelona stroke registry", Cephalalgia, 23, pp.389~394 (2003)
5. Wolf ME, "Clinical and MRI characteristics of acute migrainous infarction", Neurology, 76, pp.1911~1917 (2011)
6. Laurell K, "Migrainous infarction : a Nordic multicenter study", Eur J Neurol, 18, pp.1220~1226 (2011)
7. Olesen J, "Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine", Ann Neurol, 9, pp.344~352 (1981)
8. Lauritzen M, "Changes in regional cerebral blood flow during the course of classic migraine attacks", Ann Neurol, 13, pp.633~641 (1983)
9. Denuelle M, "Posterior cerebral hypoperfusion in migraine without aura", Cephalalgia, 28, pp.856~862 (2008)
10. Woods RP, "Brief report : bilateral spreading cerebral hypoperfusion during spontaneous migraine headache", N Engl J Med, 331, pp.1689~1692 (1994)
11. Dreier JP, "The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease", Nat Med, 17, pp.439~447 (2011)
12. Gursoy-Ozdemir Y, "Cortical spreading depression activates and upregulates MMP-9", J Clin Invest, 113, pp.1447~1455 (2004)
13. Leira R, "Mmp-9 immunoreactivity in acute migraine", Headache, 47, pp.698~702 (2007)
14. Imamura K, "Increased plasma matrix metalloproteinase-9 levels in migraineurs", Headache, 48, pp.135~139 (2008)
15. Welch KM, "Migraine-related stroke in the context of the International Headache Society classification of head pain", Arch Neurol, 47, pp.458~462 (1990)
16. Broderick JP, "Migraine-related strokes. Clinical profile and prognosis in 20 patients", Arch Neurol, 44, pp.868~871 (1987)
17. Henrich JB, "Stroke and migraine in the Oxfordshire Community Stroke Project", J Neurol, 233, pp.257~262 (1986)
18. Women CGftSoSiY, "Oral contraceptives and stroke in young women", JAMA, 231, pp.718~722 (1975)
19. Carolei A, "History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young", Lancet, 347, pp.1503~1506 (1996)
20. Lidegaard O, "Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease", Br J Obstet Gynaecol, 102, pp.153~159 (1995)
21. Tzourio C, "Migraine and risk of ischaemic stroke : a case-control study", BMJ, 307, pp.289~292 (1993)
22. Etminan M, "Risk of ischaemic stroke in people with migraine : systematic review and meta-analysis of observational studies", BMJ, 330, pp.63~ (2005)
23. Schurks M, "Migraine and cardiovascular disease: systematic review and meta-analysis", BMJ, 339, pp.b3914~ (2009)
24. Spector JT, "Migraine headache and ischemic stroke risk : an updated meta-analysis", Am J Med, 123, pp.612~624 (2010)
25. Kurth T, "Migraine, vascular risk, and cardiovascular events in women: prospective cohort study", BMJ, 337, pp.a636~ (2008)
26. Li L, "Age-specific association of migraine with cryptogenic TIA and stroke : population-based study", Neurology, 85, pp.1444~1451 (2015)
27. Monteith TS, "Migraine and risk of stroke in older adults : Northern Manhattan Study", Neurology, 85, pp.715~721 (2015)
28. Goldstein LB, "Guidelines for the primary prevention of stroke : a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2011, pp.42, 517~584
29. Kurth T, "Migraine frequency and risk of cardiovascular disease in women", Neurology, 73, pp.581~588 (2009)
30. MacClellan LR, "Probable migraine with visual aura and risk of ischemic stroke : the stroke prevention in young women study", Stroke, 38, pp.2438~2445 (2007)
31. Buring JE, "Migraine and subsequent risk of stroke in the Physicians’ Health Study", Arch Neurol, 52, pp.129~134 (1995)
32. Gudmundsson LS, "Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study", BMJ, 341, pp.c3966~ (2010)
33. Pezzini A, "Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect", Stroke, 38, pp.3145~3151 (2007)
34. Schurks M, "Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease", Neurology, 71, pp.505~513 (2008)
35. Lea RA, "The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura", BMC Med, 2, pp.3~ (2004)
36. Samaan Z, "Methylenetetrahydrofolate reductase gene variant(MTHFR C677T)and migraine : a case control study and meta-analysis", BMC Neurol, 11, pp.66~ (2011)
37. Zhang JH, "Genetic predisposition to neurological symptoms in lacunar infarction", Cerebrovasc Dis, 17, pp.273~279 (2004)
38. Kowa H, "Association of the insertion", deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura, 2005, pp.374, 129~131
39. Paterna S, "Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura", Eur Neurol, 43, pp.133~136 (2000)
40. Gormley P, "Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine", bioRxiv (2015)[DOI]
41. Malik R, "Shared genetic basis for migraine and ischemic stroke : a genome-wide analysis of common variants", Neurology, 84, pp.2132~2145 (2015)
42. Tietjen GE, "Migraine and biomarkers of endothelial activation in young women", Stroke, 40, pp.2977~2982 (2009)
43. Tietjen GE, "Increased von Willebrand factor in migraine", Neurology, 57, pp.334~336 (2001)
44. Rodriguez-Osorio X, "Endothelial progenitor cells : a new key for endothelial dysfunction in migraine", Neurology, 79, pp.474~479 (2012)
45. Lee ST, "Decreased number and function of endothelial progenitor cells in patients with migraine", Neurology, 70, pp.1510~1517 (2008)
46. Oterino A, "Analysis of endothelial precursor cells in chronic migraine : a case-control study", Cephalalgia, 33, pp.236~244 (2013)
47. Liman TG, "Circulating endothelial microparticles in female migraineurs with aura", Cephalalgia, 35, pp.88~94 (2015)
48. Ikeda K, "Pulse wave velocity study in middle-aged migraineurs at low cardiovascular disease risk", Headache, 51, pp.1239~1244 (2011)
49. Napoli R, "Vascular smooth muscle cell dysfunction in patients with migraine", Neurology, 72, pp.2111~2114 (2009)
50. Vanmolkot FH, "Altered arterial function in migraine of recent onset", Neurology, 68, pp.1563~1570 (2007)
51. Rajan R, "Interictal cerebral and systemic endothelial dysfunction in patients with migraine : a casecontrol study", J Neurol Neurosurg Psychiatry, 86, pp.1253~1257 (2015)
52. Perko D, "Endothelium-dependent vasodilatation in migraine patients", Cephalalgia, 31, pp.654~660 (2011)
53. Vanmolkot FH, "Endothelial function in migraine : a cross-sectional study", BMC Neurol, 10, pp.119~ (2010)
54. Perko D, "Associations between cerebral and systemic endothelial function in migraine patients : a post-hoc study", BMC Neurol, 11, pp.146~ (2011)
55. Sarchielli P, "Platelet-activating factor(PAF)in internal jugular venous blood of migraine without aura patients assessed during migraine attacks", Cephalalgia, 24, pp.623~630 (2004)
56. Kovacs K, "Platelet aggregation of migraineurs during and between attacks", Cephalalgia, 10, pp.161~165 (1990)
57. Cesar JM, "Increased levels of plasma von Willebrand factor in migraine crisis", Acta Neurol Scand, 91, pp.412~413 (1995)
58. Moschiano F, "Coagulation abnormalities in migraine and ischaemic cerebrovascular disease: a link between migraine and ischaemic stroke?", Neurol Sci, 25(Suppl 3), pp.S126~S128 (2004)
59. Hering-Hanit R, "Evidence for activation of the coagulation system in migraine with aura", Cephalalgia, 21, pp.137~139 (2001)
60. Tzourio C, "Migraine and the risk of cervical artery dissection : a case-control study", Neurology, 59, pp.435~437 (2002)
61. Pezzini A, "History of migraine and the risk of spontaneous cervical artery dissection", Cephalalgia, 25, pp.575~580 (2005)
62. Rubinstein SM, "A systematic review of the risk factors for cervical artery dissection", Stroke, 36, pp.1575~1580 (2005)
63. Rist PM, "Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis", Cephalalgia, 31, pp.886~896 (2011)
64. Debette S, "The genetics of cervical artery dissection:a systematic review", Stroke, 40, pp.e459~e466 (2009)
65. Tzourio C, "Serum elastase activity is elevated in migraine", Ann Neurol, 47, pp.648~651 (2000)
66. Debette S, "Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection", Nat Genet, 47, pp.78~83 (2015)
67. Schwedt TJ, "Patent foramen ovale and migraine : a quantitative systematic review", Cephalalgia, 28, pp.531~540 (2008)
68. Del Sette M, "Migraine with aura and right-to-left shunt on transcranial Doppler : a case-control study", Cerebrovasc Dis, 8, pp.327~330 (1998)
69. Reisman M, "Migraine headache relief after transcatheter closure of patent foramen ovale", J Am Coll Cardiol, 45, pp.493~495 (2005)
70. Anzola GP, "Shuntassociated migraine responds favorably to atrial septal repair : a case-control study", Stroke, 37, pp.430~434 (2006)
71. Rundek T, "Patent foramen ovale and migraine : a cross-sectional study from the Northern Manhattan Study(NOMAS)", Circulation, 118, pp.1419~1424 (2008)
72. Garg P, "Lack of association between migraine headache and patent foramen ovale : results of a case-control study", Circulation, 121, pp.1406~1412 (2010)
73. Dowson A, "Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache", Circulation, 117, pp.1397~1404 (2008)
74. Anzola GP, "Different degrees of right-to-left shunting predict migraine and stroke : data from 420 patients", Neurology, 66, pp.765~767 (2006)
75. Adami A, "Right-to-left shunt does not increase white matter lesion load in migraine with aura patients", Neurology, 71, pp.101~107 (2008)
76. Yoon GJ, "Right-to-left shunts as a cause of juxtacortical spots in patients with migraine", Eur J Neurol, 19, pp.1086~1092 (2012)
77. Krause I, "Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome", Ann Rheum Dis, 64, pp.1490~1493 (2005)
78. Tietjen GE, "Sneddon’s syndrome: another migraine-stroke association?", Cephalalgia, 26, pp.225~232 (2006)
79. Tjensvoll AB, "Migraine is frequent in patients with systemic lupus erythematosus : a case-control study", Cephalalgia, 31, pp.401~408 (2011)
80. Swartz RH, "Migraine is associated with magnetic resonance imaging white matter abnormalities : a meta-analysis", Arch Neurol, 61, pp.1366~1368 (2004)
81. Bashir A, "Migraine and structural changes in the brain : a systematic review and meta-analysis", Neurology, 81, pp.1260~1268 (2013)
82. Kruit MC, "Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study", Brain, 128, pp.2068~2077 (2005)
83. Monteith T, "Migraine, white matter hyperintensities, and subclinical brain infarction in a diverse community: the northern Manhattan study", Stroke, 45, pp.1830~1832 (2014)
84. Kruit MC, "Migraine as a risk factor for subclinical brain lesions", JAMA, 291, pp.427~434 (2004)
85. Trauninger A, "Risk factors of migraine-related brain white matter hyperintensities : an investigation of 186 patients", J Headache Pain, 12, pp.97~103 (2011)
86. Erdelyi-Botor S, "Changes of migraine-related white matter hyperintensities after 3 years : a longitudinal MRI study", Headache, 55, pp.55~70 (2015)
87. Dinia L, "White matter lesions progression in migraine with aura : a clinical and MRI longitudinal study", J Neuroimaging, 23, pp.47~52 (2013)
88. Hamedani AG, "Migraine and white matter hyperintensities : the ARIC MRI study", Neurology, 81, pp.1308~1313 (2013)
89. Palm-Meinders IH, "Structural brain changes in migraine", JAMA, 308, pp.1889~1897 (2012)
90. Paemeleire K, "Brain lesions and cerebral functional impairment in migraine patients", J Neurol Sci, 283, pp.134~136 (2009)
91. Le Pira F, "Executive dysfunctions in migraine with and without aura: what is the role of white matter lesions?", Headache, 54, pp.125~130 (2014)
92. Kurth T, "Migraine and risk of haemorrhagic stroke in women: prospective cohort study", BMJ, 341, pp.c3659~ (2010)
93. Sacco S, "Migraine and hemorrhagic stroke : a meta-analysis", Stroke, 44, pp.3032~3038 (2013)
94. Kuo CY, "Increased risk of hemorrhagic stroke in patients with migraine: a population-based cohort study", PLoS One, 8, pp.e55253~ (2013)
95. Gaist D, "Migraine and risk of hemorrhagic stroke : a study based on data from general practice", J Headache Pain, 15, pp.74~ (2014)
96. Chabriat H, "Cadasil", Lancet Neurol, 8, pp.643~653 (2009)
97. Desmond DW, "The natural history of CADASIL : a pooled analysis of previously published cases", pp.1230~1233 (1999), Stroke
98. Bousser M, "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy : from stroke to vessel wall physiology", J Neurol Neurosurg Psychiatry, 70, pp.285~287 (2001)
99. Peters N, "A two-year clinical follow-up study in 80 CADASIL subjects : progression patterns and implications for clinical trials", Stroke, 35, pp.1603~1608 (2004)
100. Choi JC, "Headache among CADASIL patients with R544C mutation: prevalence, characteristics, and associations", Cephalalgia, 34, pp.22~28 (2014)
101. Vahedi K, "Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL", Arch Neurol, 61, pp.1237~1240 (2004)
102. Joutel A, "Notch3 mutations in CADASIL, a hereditary adultonset condition causing stroke and dementia", Nature, 383, pp.707~710 (1996)
103. Peters N, "Spectrum of mutations in biopsy-proven CADASIL : implications for diagnostic strategies", Arch Neurol, 62, pp.1091~1094 (2005)
104. Markus HS, "Diagnostic strategies in CADASIL", Neurology, 59, pp.1134~1138 (2002)
105. O’Sullivan M, "MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL", Neurology, 56, pp.628~634 (2001)
106. Pavlakis SG, "Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome", Ann Neurol, 16, pp.481~488 (1984)
107. Zach V, "Headache associated with moyamoya disease : a case story and literature review", J Headache Pain, 11, pp.79~82 (2010)
108. Park-Matsumoto YC, "Migraine with aura-like headache associated with moyamoya disease", Acta Neurol Scand, 100, pp.119~121 (1999)
109. M. R. Siddiqui, "Moyamoya disease presented as a case of hemiplegic migraine", Case Reports, 2010, pp.bcr0220102764~bcr0220102764 (2010), BMJ[DOI]
110. Tfelt-Hansen P, "Ergotamine in the acute treatment of migraine:a review and European consensus", Brain, 123(Pt 1), pp.9~18 (2000)
111. Wammes-van der Heijden EA, "Risk of ischemic complications related to the intensity of triptan and ergotamine use", Neurology, 67, pp.1128~1134 (2006)
112. Miller M, "Refractory caffeine and ergot-induced cervico-cerebral vasospasm and stroke treated with combined medical and endovascular approach", Neuroradiology, 54, pp.77~79 (2012)
113. Wooltorton E, "Risk of stroke, gangrene from ergot drug interactions", CMAJ, 168, pp.1015~ (2003)
114. Velentgas P, "Severe vascular events in migraine patients", Headache, 44, pp.642~651 (2004)
115. Hall GC, "Triptans in migraine:the risks of stroke, cardiovascular disease, and death in practice", Neurology, 62, pp.563~568 (2004)
116. Cavazos JE, "Sumatriptan-induced stroke in sagittal sinus thrombosis", Lancet, 343, pp.1105~1106 (1994)
117. Vijayan N, "Spinal cord infarction during use of zolmitriptan : a case report", Headache, 40, pp.57~60 (2000)
118. Shinohara Y, "Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial", Lancet Neurol, 9, pp.959~968 (2010)
119. Birk S, "The headache-inducing effect of cilostazol in human volunteers", Cephalalgia, 26, pp.1304~1309 (2006)
120. Guo S, "Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase", Brain, 137, pp.2951~2959 (2014)
121. Kruuse C, "Dipyridamole may induce migraine in patients with migraine without aura", Cephalalgia, 26, pp.925~933 (2006)
122. Fragoso YD, "Reduction of migraine attacks during the use of warfarin", Headache, 37, pp.667~668 (1997)
123. Buring JE, "Low-dose aspirin for migraine prophylaxis", JAMA, 264, pp.1711~1713 (1990)
124. Wilmshurst PT, "Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects", Heart, 91, pp.1173~1175 (2005)
125. Chambers JB, "Clopidogrel as prophylactic treatment for migraine: a pilot randomised, controlled study", Cephalalgia, 34, pp.1163~1168 (2014)
126. Evers S, "EFNS guideline on the drug treatment of migraine–revised report of an EFNS task force", Eur J Neurol, 16, pp.968~981 (2009)
127. Silberstein SD, "Evidence-based guideline update : pharmacologic treatment for episodic migraine prevention in adults : report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society", Neurology, 78, pp.1337~1345 (2012)
128. Tronvik E, "Prophylactic treatment of migraine with an angiotensin II receptor blocker : a randomized controlled trial", JAMA, 289, pp.65~69 (2003)
129. Charles JA, "Prevention of migraine with olmesartan in patients with hypertension", prehypertension, 2006, pp.46, 503~507
130. Schrader H, "Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study", BMJ, 322, pp.19~22 (2001)
131. Liberopoulos EN, "Could statins be useful in the treatment of patients with migraine?", Headache, 46, pp.672~675 (2006)
132. Medeiros FL, "Simvastatin for migraine prevention", Headache, 47, pp.855~856 (2007)
133. Buettner C, "Simvastatin and Vitamin D for Migraine Prevention: a Randomized Controlled Trial", Ann Neurol (2015)
134. Yin Z, "Atorvastatin attenuates NF-kappaB activation in trigeminal nucleus caudalis in a rat model of migraine", Neurosci Lett, 465, pp.61~65 (2009)
135. Bucelli RC, "Statins decrease expression of the proinflammatory neuropeptides calcitonin gene-related peptide and substance P in sensory neurons", J Pharmacol Exp Ther, 324, pp.1172~1180 (2008)

관련 논문AI추천